Does RIBOCICLIB Cause Skin lesion? 121 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Skin lesion have been filed in association with RIBOCICLIB (KISQALI). This represents 0.4% of all adverse event reports for RIBOCICLIB.
121
Reports of Skin lesion with RIBOCICLIB
0.4%
of all RIBOCICLIB reports
7
Deaths
27
Hospitalizations
How Dangerous Is Skin lesion From RIBOCICLIB?
Of the 121 reports, 7 (5.8%) resulted in death, 27 (22.3%) required hospitalization, and 11 (9.1%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 121 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
Which RIBOCICLIB Alternatives Have Lower Skin lesion Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN